Immuron Ltd ADR
Biotechnology
Healthcare
IMRN
5.71 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.90
52 week high
2.81
high
1.93
52 week low
0.00
low
1.87
growth
-24.70 %
previous Close
1.94
P/E ratio
market cap
9.79 M
div yield
0
usd
Mar 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
0.00 %
62.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top